New SEC Form D filing

Platform Therapeutics, Inc., 2026-08-27

A new SEC Form D private-offering notice from Andover, MA, a $4,000,000 filer-stated offering target in Biotech. The source filing is one click away.

What this filing says

Platform Therapeutics, Inc. site↗ Verified via SEC Form D

Clinical stage biotech developing therapies to prevent toxic side effects of chemotherapy, including kidney injury and hearing loss from platinum based chemo and aminoglycoside antibiotics

Filed 2026-08-27Filed to raise $4,000,000First money in 2026-08-12Raised so far $1,750,000HQ (as filed) Andover, MASector Biotech web-verified against the company’s own siteStage (inferred) SeedCall status Call-ready
Source linked the Form D on EDGAR↗Website verified ptx.life↗Named in the filing 2 executives & directors
Open this row on the live feed →More new filings in Massachusetts →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source